Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth.

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.